Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 157,797,728
  • Shares Outstanding, K 1,479,446
  • Annual Sales, $ 16,747 M
  • Annual Income, $ 1,854 M
  • EBIT $ 3,715 M
  • EBITDA $ 5,370 M
  • 60-Month Beta 0.68
  • Price/Sales 9.37
  • Price/Cash Flow 28.73
  • Price/Book 6.91

Options Overview Details

View History
  • Implied Volatility 21.48% ( +0.08%)
  • Historical Volatility 28.54%
  • IV Percentile 42%
  • IV Rank 17.90%
  • IV High 52.68% on 04/04/25
  • IV Low 14.68% on 08/13/24
  • Put/Call Vol Ratio 0.22
  • Today's Volume 11,733
  • Volume Avg (30-Day) 14,090
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 235,910
  • Open Int (30-Day) 272,916

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.72
  • Number of Estimates 10
  • High Estimate 0.73
  • Low Estimate 0.72
  • Prior Year 0.62
  • Growth Rate Est. (year over year) +16.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.70 +15.06%
on 04/21/25
106.72 -0.06%
on 05/19/25
+11.54 (+12.13%)
since 04/17/25
3-Month
85.98 +24.05%
on 04/07/25
106.72 -0.06%
on 05/19/25
+0.99 (+0.94%)
since 02/19/25
52-Week
71.88 +48.39%
on 08/05/24
107.17 -0.48%
on 02/05/25
+32.01 (+42.88%)
since 05/17/24

Most Recent Stories

More News
ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues

Zimmer Biomet’s ZBH strategic priorities, new product launches and focus on international expansion bolster our confidence in this stock. Yet, the difficult macroeconomic situation and FX issues are...

ZBH : 95.77 (-1.22%)
BSX : 106.66 (+0.58%)
HIMS : 62.34 (-3.57%)
CAH : 153.86 (-0.25%)
Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs

Abbott ABT recently announced results from its REFLECT real-world studies, conducted using data from the comprehensive Swedish National Diabetes Register. The findings revealed that the company’s FreeStyle...

ABT : 135.55 (+0.56%)
BSX : 106.66 (+0.58%)
HIMS : 62.34 (-3.57%)
CAH : 153.86 (-0.25%)
Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch

Medtronic plc MDT is scheduled to report fourth-quarter and full-year fiscal 2025 results on May 21, before the opening bell.In the last reported quarter, the company’s adjusted earnings of $1.39 exceeded...

ABT : 135.55 (+0.56%)
BSX : 106.66 (+0.58%)
MDT : 86.97 (+0.61%)
Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy?

Despite facing a challenging industry-wide investment climate driven by tariffs, Abbott ABT has managed to achieve an 18.8% gain so far in 2025, outperforming the industry, its benchmark, and the company’s...

ABT : 135.55 (+0.56%)
BSX : 106.66 (+0.58%)
MDT : 86.97 (+0.61%)
The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific

For Immediate ReleaseChicago, IL – May 6, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

ABT : 135.55 (+0.56%)
BSX : 106.66 (+0.58%)
JNJ : 152.49 (+0.77%)
GEHC : 73.10 (-0.04%)
MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know

After two strong years, 2025 was expected to mark another high-growth chapter for the MedTech industry, particularly in health technology. Instead, recent first-quarter results show a different story....

ABT : 135.55 (+0.56%)
BSX : 106.66 (+0.58%)
JNJ : 152.49 (+0.77%)
GEHC : 73.10 (-0.04%)
Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink?

Boston Scientific has outpaced the broader market over the past year and analysts are highly upbeat about its future prospects.

BCS : 17.73 (+1.78%)
BSX : 106.66 (+0.58%)
$SPX : 5,963.60 (+0.09%)
IHI : 63.01 (+0.22%)
2 S&P 500 Stocks Worth Investigating and 1 to Avoid

2 S&P 500 Stocks Worth Investigating and 1 to Avoid

SYK : 394.69 (+0.12%)
BSX : 106.66 (+0.58%)
VTRS : 8.76 (-0.90%)
Zacks Investment Ideas feature highlights: Boston Scientific, Meta Platforms and Microsoft

For Immediate ReleaseChicago, IL – May 2, 2025 – Today, Zacks Investment Ideas feature highlights Boston Scientific BSX, Meta Platforms META and Microsoft MSFT.These 3 Stocks Soared Following Quarterly...

MSFT : 458.87 (+1.01%)
META : 640.43 (+0.01%)
BSX : 106.66 (+0.58%)
These 3 Stocks Soared Following Strong Quarterly Results

The 2025 Q1 earnings cycle is in full swing, with many companies on the docket to reveal quarterly results in the coming weeks.Guidance is a key factor in this cycle, more so than we’ve seen in recent...

MSFT : 458.87 (+1.01%)
META : 640.43 (+0.01%)
BSX : 106.66 (+0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 108.28
2nd Resistance Point 107.50
1st Resistance Point 107.08
Last Price 106.66
1st Support Level 105.88
2nd Support Level 105.10
3rd Support Level 104.68

See More

52-Week High 107.17
Last Price 106.66
Fibonacci 61.8% 93.69
Fibonacci 50% 89.52
Fibonacci 38.2% 85.36
52-Week Low 71.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »